Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.

Autor: Khoury K; University of Alabama at Birmingham, Birmingham, AL, USA., Meisel JL; Emory University, Atlanta, GA, USA., Yau C; University of California San Francisco, San Francisco, CA, USA., Rugo HS; University of California San Francisco, San Francisco, CA, USA., Nanda R; University of Chicago, Chicago, IL, USA., Davidian M; North Carolina State University, Raleigh, NC, USA., Tsiatis B; North Carolina State University, Raleigh, NC, USA., Chien AJ; University of California San Francisco, San Francisco, CA, USA., Wallace AM; University of California San Diego, San Diego, CA, USA., Arora M; University of California Davis, Davis, CA, USA., Rozenblit M; Yale University, New Haven, CT, USA., Hershman DL; Columbia University, New York, NY, USA., Zimmer A; Oregon Health Sciences University, Portland, OR, USA., Clark AS; University of Pennsylvania, Philadelphia, PA, USA., Beckwith H; University of Minnesota, Minneapolis, MN, USA., Elias AD; University of Colorado Denver, Denver, CO, USA., Stringer-Reasor E; University of Alabama at Birmingham, Birmingham, AL, USA., Boughey JC; The Mayo Clinic, Rochester, MN, USA., Nangia C; HOAG Family Cancer Institute, Newport Beach, CA, USA., Vaklavas C; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Omene C; Cooperman Barnabas Medical Center, New Brunswick, NJ, USA.; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Albain KS; Stritch School of Medicine, Loyola University Chicago, Chicago, IL, USA., Kalinsky KM; Emory University, Atlanta, GA, USA., Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA., Tseng J; City of Hope Orange County Lennar Foundation Cancer Center, Orange County, CA, USA., Roussos Torres ET; University of Southern California, Los Angeles, CA, USA., Thomas B; Sparrow Health System, Lansing, MI, USA., Thomas A; Wake Forest University, Winston-Salem, NC, USA., Sanford A; Sanford Health, Sioux Falls, SD, USA., Balassanian R; University of California San Francisco, San Francisco, CA, USA., Ewing C; University of California San Francisco, San Francisco, CA, USA., Yeung K; University of California San Diego, San Diego, CA, USA., Sauder C; University of California Davis, Davis, CA, USA., Sanft T; Yale University, New Haven, CT, USA., Pusztai L; Yale University, New Haven, CT, USA., Trivedi MS; Columbia University, New York, NY, USA., Outhaythip A; Oregon Health Sciences University, Portland, OR, USA., Li W; University of California San Francisco, San Francisco, CA, USA., Onishi N; University of California San Francisco, San Francisco, CA, USA., Asare AL; University of California San Francisco, San Francisco, CA, USA.; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA., Beineke P; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA., Norwood P; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA., Brown-Swigart L; University of California San Francisco, San Francisco, CA, USA., Hirst GL; University of California San Francisco, San Francisco, CA, USA., Matthews JB; University of California San Francisco, San Francisco, CA, USA., Moore B; Wake Forest University, Winston-Salem, NC, USA., Fraser Symmans W; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Price E; University of California San Francisco, San Francisco, CA, USA., Beedle C; University of California San Francisco, San Francisco, CA, USA., Perlmutter J; The Gemini Group, Ann Arbor, MI, USA., Pohlmann P; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shatsky RA; University of California San Diego, San Diego, CA, USA., DeMichele A; University of Pennsylvania, Philadelphia, PA, USA., Yee D; University of Minnesota, Minneapolis, MN, USA., van 't Veer LJ; University of California San Francisco, San Francisco, CA, USA., Hylton NM; University of California San Francisco, San Francisco, CA, USA., Esserman LJ; University of California San Francisco, San Francisco, CA, USA. laura.esserman@ucsf.edu.

Publikováno v: Nature medicine [Nat Med] 2024 Sep 14. Date of Electronic Publication: 2024 Sep 14.

Patient-centered dosing: oncologists' perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC).

Autor: Loeser AL; Patient-Centered Dosing Initiative, Salt Lake City, UT, USA., Gao L; Yale School of Medicine, New Haven, CT, USA. lgao11@partners.org., Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Burkard ME; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Kalinsky KM; Winship Cancer Institute at Emory University, Atlanta, GA, USA., Peppercorn J; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Rugo HS; University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA., Carlson M; Patient-Centered Dosing Initiative, Salt Lake City, UT, USA., Cowden J; Patient-Centered Dosing Initiative, Salt Lake City, UT, USA., Glenn L; Patient-Centered Dosing Initiative, Salt Lake City, UT, USA., Maues J; Patient-Centered Dosing Initiative, Salt Lake City, UT, USA., McGlown S; Patient-Centered Dosing Initiative, Salt Lake City, UT, USA., Ni A; Division of Biostatistics, Ohio State University, Columbus, OH, USA., Padron N; Patient-Centered Dosing Initiative, Salt Lake City, UT, USA., Lustberg M; Smilow Cancer Hospital, Yale Cancer Center, New Haven, CT, USA.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Dec; Vol. 196 (3), pp. 549-563. Date of Electronic Publication: 2022 Oct 06.

Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Autor: Boughey JC; 1Department of Surgery, Mayo Clinic, Rochester, MN USA., Alvarado MD; 2UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA., Lancaster RB; 3Department of Surgery, University of Alabama at Birmingham, Birmingham, AL USA., Symmans WF; 4Department of Pathology, MD Anderson Cancer Center, Houston, TX USA., Mukhtar R; 2UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA., Wong JM; 2UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA., Ewing CA; 2UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA., Potter DA; 5Department of Medicine, University of Minnesota, Minneapolis, MN USA., Tuttle TM; 6Department of Surgery, University of Minnesota, Minneapolis, MN USA., Hieken TJ; 1Department of Surgery, Mayo Clinic, Rochester, MN USA., Carter JM; 7Department of Pathology, Mayo Clinic, Rochester, MN USA., Jakub JW; 1Department of Surgery, Mayo Clinic, Rochester, MN USA., Kaplan HG; 8Swedish, Swedish Cancer Institute, Seattle, WA USA., Buchanan CL; 8Swedish, Swedish Cancer Institute, Seattle, WA USA., Jaskowiak NT; 9Department of Surgery, University of Chicago, Chicago, IL USA., Sattar HA; 10Department of Pathology, University of Chicago, Chicago, IL USA., Mueller J; 10Department of Pathology, University of Chicago, Chicago, IL USA., Nanda R; 11Department of Hematology and Oncology, University of Chicago, Chicago, IL USA., Isaacs CJ; Georgetown University Medical Center, Lombardi Cancer Center, Washington, USA., Pohlmann PR; Georgetown University Medical Center, Lombardi Cancer Center, Washington, USA., Lynce F; Georgetown University Medical Center, Lombardi Cancer Center, Washington, USA., Tousimis EA; Georgetown University Medical Center, Lombardi Cancer Center, Washington, USA., Zeck JC; Georgetown University Medical Center, Lombardi Cancer Center, Washington, USA., Lee MC; 13Moffitt Cancer Center, Tampa, FL USA., Lang JE; 14University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA USA., Mhawech-Fauceglia P; 14University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA USA., Rao R; 15Columbia University Medical Center, New York, NY USA., Taback B; 15Columbia University Medical Center, New York, NY USA., Goodellas C; 16Loyola University Medical Centre, Maywood, IL USA., Chen M; 15Columbia University Medical Center, New York, NY USA., Kalinsky KM; 15Columbia University Medical Center, New York, NY USA., Hibshoosh H; 15Columbia University Medical Center, New York, NY USA., Killelea B; 17Department of Surgery and Department of Medical Oncology, Yale University, New Haven, CT USA., Sanft T; 17Department of Surgery and Department of Medical Oncology, Yale University, New Haven, CT USA., Hirst GL; 2UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA., Asare S; Quantum Leap Health Care Collaborative, San Francisco, CA USA., Matthews JB; 2UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA., Perlmutter J; Patient Representative, Ann Arbor, Michigan USA., Esserman LJ; 2UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA.

Publikováno v: NPJ breast cancer [NPJ Breast Cancer] 2019 Jan 02; Vol. 5, pp. 2. Date of Electronic Publication: 2019 Jan 02 (Print Publication: 2019).